Clincosm LogoSign in Get a demo

plexiform neurofibroma

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group

Not yet recruiting
  • Neurofibromatosis 1
  • +2 more
  • Test group (Group A): FCN-159 8 mg, orally, once daily;
  • Control group (Group B): Placebo, orally, once daily;
  • (no location specified)
Jun 16, 2023

Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1) Trial in United States (Mirdametinib (PD-0325901) oral capsule or

Active, not recruiting
  • Plexiform Neurofibroma
  • Neurofibromatosis Type 1 (NF1)
  • Mirdametinib (PD-0325901) oral capsule or dispersible tablet
  • Birmingham, Alabama
  • +49 more
Nov 17, 2022

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial in China, Spain, United States (FCN-159)

Recruiting
  • Neurofibromatosis 1
  • +2 more
  • Los Angeles, California
  • +11 more
Jul 25, 2022

Neurofibromatosis Type 1, Plexiform Neurofibroma Trial in United States (Binimetinib)

Active, not recruiting
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma
  • Birmingham, Alabama
  • +21 more
Dec 4, 2021

Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

Recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • London, United Kingdom
  • +1 more
Nov 11, 2021

PET/MRI in CNS and Extra-CNS Tumors of Neurofibromatosis-1 (NF1)

Completed
  • Neurofibromatosis-1
  • +2 more
    • Chapel Hill, North Carolina
      University of North Carolina-Chapel Hill
    May 11, 2021

    Neurofibromatosis 1, Neurofibroma, Atypical Neurofibroma Trial in Washington (Whole Body MRI)

    Active, not recruiting
    • Neurofibromatosis 1
    • +5 more
    • Whole Body MRI
    • Washington, District of Columbia
      Children's National Health System
    Feb 26, 2021

    Neurofibromatosis Type I, Plexiform Neurofibroma Trial in Birmingham, Bethesda (Nexavar (BAY 43-9006) (Sorafenib), Toxicity,

    Completed
    • Neurofibromatosis Type I
    • Plexiform Neurofibroma
    • Nexavar (BAY 43-9006) (Sorafenib)
    • +5 more
    • Birmingham, Alabama
    • +1 more
    Dec 11, 2019

    Plexiform Neurofibroma Trial in Pittsburgh (PEG-Intron)

    Completed
    Has Results
    • Plexiform Neurofibroma
    • Pittsburgh, Pennsylvania
      Children's Hospital of Pittsburgh of UPMC
    Oct 5, 2017

    Neurofibromatosis Type 1, Plexiform Neurofibroma, Spinal Cord Neurofibroma Trial in United States (Cediranib Maleate)

    Terminated
    Has Results
    • Neurofibromatosis Type 1
    • +2 more
    • Cediranib Maleate
    • Birmingham, Alabama
    • +8 more
    Jul 21, 2017

    Neurofibromatosis Type 1, Plexiform Neurofibroma, Neurofibromatoses Trial in Creteil (RAD001: Everolimus)

    Completed
    • Neurofibromatosis Type 1
    • +2 more
    • RAD001: Everolimus
    • Creteil, France
      Henri Mondor Hospital
    Nov 13, 2014